155 related articles for article (PubMed ID: 16724423)
21. The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.
Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
Scand J Infect Dis; 2014 Dec; 46(12):832-7. PubMed ID: 25229166
[TBL] [Abstract][Full Text] [Related]
22. Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.
Deplano A; Hallin M; Bustos Sierra N; Michel C; Prevost B; Martiny D; Yin N
J Antimicrob Chemother; 2023 Aug; 78(8):2061-2065. PubMed ID: 37358399
[TBL] [Abstract][Full Text] [Related]
23. Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
Aubin GG; Bémer P; Guillouzouic A; Launay E; Geffroy L; Touchais S; Corvec S
Infect Dis (Lond); 2016 Sep; 48(9):699-702. PubMed ID: 27194514
[TBL] [Abstract][Full Text] [Related]
24. Increasing resistance to fusidic acid among clinical isolates of MRSA.
Wang JT; Huang IW; Chang SC; Tan MC; Lai JF; Chen PY; Lauderdale TL
J Antimicrob Chemother; 2017 Feb; 72(2):616-618. PubMed ID: 27733516
[No Abstract] [Full Text] [Related]
25. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
Vogel A; Lennon D; Best E; Leversha A
N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855
[TBL] [Abstract][Full Text] [Related]
26. Fusidic acid resistance in Staphylococcus aureus.
Dobie D; Gray J
Arch Dis Child; 2004 Jan; 89(1):74-7. PubMed ID: 14709515
[TBL] [Abstract][Full Text] [Related]
27. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
[TBL] [Abstract][Full Text] [Related]
28. In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid.
Tünger O; Arisoy A; Kurutepe S; Akçali S; Ozbakkaloğlu B
Int J Antimicrob Agents; 2001 Nov; 18(5):445-7. PubMed ID: 11711260
[No Abstract] [Full Text] [Related]
29. Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.
Farrell DJ; Mendes RE; Castanheira M; Jones RN
Antimicrob Agents Chemother; 2016 Jun; 60(6):3827-31. PubMed ID: 27021326
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
Afset JE; Maeland JA
Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555
[TBL] [Abstract][Full Text] [Related]
31. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway.
Tveten Y; Jenkins A; Kristiansen BE
J Antimicrob Chemother; 2002 Dec; 50(6):873-6. PubMed ID: 12461006
[TBL] [Abstract][Full Text] [Related]
32. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
Woodford N; Afzal-Shah M; Warner M; Livermore DM
J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
[TBL] [Abstract][Full Text] [Related]
34. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
Lim KT; Teh CS; Yusof MY; Thong KL
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):112-8. PubMed ID: 24336696
[TBL] [Abstract][Full Text] [Related]
35. Staphylococcal bacteraemia and endocarditis and fusidic acid.
Eykyn SJ
J Antimicrob Chemother; 1990 Feb; 25 Suppl B():33-8. PubMed ID: 2312444
[TBL] [Abstract][Full Text] [Related]
36. Rapid Emergence and Evolution of Staphylococcus aureus Clones Harboring fusC-Containing Staphylococcal Cassette Chromosome Elements.
Baines SL; Howden BP; Heffernan H; Stinear TP; Carter GP; Seemann T; Kwong JC; Ritchie SR; Williamson DA
Antimicrob Agents Chemother; 2016 Apr; 60(4):2359-65. PubMed ID: 26856837
[TBL] [Abstract][Full Text] [Related]
37. Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of
Yin N; Michel C; Makki N; Deplano A; Milis A; Prevost B; Miendje-Deyi VY; Hallin M; Martiny D
Euro Surveill; 2024 May; 29(19):. PubMed ID: 38726693
[TBL] [Abstract][Full Text] [Related]
38. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
Whitby M
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S67-71. PubMed ID: 10528788
[TBL] [Abstract][Full Text] [Related]
39. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.
O'Neill AJ; Larsen AR; Skov R; Henriksen AS; Chopra I
J Clin Microbiol; 2007 May; 45(5):1505-10. PubMed ID: 17344365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
